Analyst Downgrades: Biogen Idec, NVIDIA, and Tesla

Analysts downwardly revise their ratings on Biogen Idec Inc (BIIB), NVIDIA Corporation (NVDA), and Tesla Motors Inc (TSLA)

Mar 23, 2015 at 9:32 AM
facebook X logo linkedin


Analysts are weighing in on biotech firm Biogen Idec Inc (NASDAQ:BIIB), chipmaker NVIDIA Corporation (NASDAQ:NVDA), and electric car issue Tesla Motors Inc (NASDAQ:TSLA). Here's a quick roundup of today's bearish brokerage notes on BIIB, NVDA, and TSLA.

  • BIIB is pointed 2.1% lower ahead of the bell, after Stifel downgraded Biogen Idec Inc to "hold" from "buy" (while three other firms hiked their price targets). On the charts, BIIB has been a technical outperformer, with the shares up over 40% year-to-date to hit $475.98. What's more, the security notched a record high of $480.18 last Friday. Off the charts, the drugmaker said it is dropping the "Idec" from its name as of today, as well as expanding its footprint in the treatment of Alzheimer's and ALS. In the options pits, short-term puts are more popular than usual, per BIIB's Schaeffer's put/call open interest ratio (SOIR) of 1.29, which sits in the 96th percentile of its annual range.

  • Goldman Sachs cut its opinion of NVDA to "sell" from "neutral," prompting the shares to shed about 2.9% in electronic trading. The downgrade -- attributed to risks of possibly diminishing Intel Corporation (NASDAQ:INTC) revenue -- is somewhat surprising, given that NVIDIA Corporation notched a four-year high of $23.60 before settling at $23.47 on Friday, with the shares up over 17% year-to-date. Sentiment in the options pits is echoing today's downgrade, though, as NVDA's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.64 sits in the 73rd percentile of its annual range. Additionally, the brokerage bunch is mostly pessimistic on the stock, as 57% of covering analysts rate the stock a "hold" or worse. A capitulation of bears in the options pits and/or the analyst community could create tailwinds.

  • TSLA -- which last week said its flagship Model S will have autonomous driving features available to consumers as soon as this summer -- was hit with a negative analyst note. Pacific Crest cut its price target on the equity by $7 to $293. Looking back, Tesla Motors Inc has been slipping, with the shares down roughly 32% from their Sept. 4 all-time high of $291.41 to close Friday at $198.08. Accordingly, bearish sentiment has been ruling the options pits, as TSLA's 10-day ISE/CBOE/PHLX put/call volume ratio of 1.18 ranks higher than 93% of all equivalent ratings taken over the past 12 months.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI